Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Malignant hepatobiliary neoplasms
ADR ID BADD_A02647
ADR Hierarchy
09      Hepatobiliary disorders
09.04      Hepatobiliary neoplasms
09.04.02      Malignant hepatobiliary neoplasms
Description Not Available
MedDRA Code 10025577
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D01978Ruxolitinib
BADD_D01992Saxagliptin
BADD_D02018Sildenafil
BADD_D02026Simvastatin
BADD_D02028Sirolimus
BADD_D02029Sitagliptin
BADD_D02053Sofosbuvir
BADD_D02058Sorafenib
BADD_D02066Spironolactone
BADD_D02100Sunitinib
BADD_D02105Tacrolimus
BADD_D02106Tadalafil
BADD_D02147Telmisartan
BADD_D02150Temozolomide
BADD_D02155Tenofovir disoproxil
BADD_D02165Teriflunomide
BADD_D02170Testosterone
BADD_D02230Tizanidine
BADD_D02231Tizanidine hydrochloride
BADD_D02236Tofacitinib
BADD_D02246Tolvaptan
BADD_D02257Trametinib
BADD_D02268Treprostinil
BADD_D02331Valsartan
BADD_D02334Vandetanib
BADD_D02342Vedolizumab
BADD_D02344Vemurafenib
BADD_D02369Voriconazole
BADD_D02373Warfarin
BADD_D02392Zoledronic acid
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages